norovirus
major
caus
foodor
waterborn
gastroenter
outbreak
human
noroviru
proteas
cleav
larg
viral
polyprotein
nonstructur
protein
essenti
viru
replic
attract
target
antivir
drug
develop
norovirus
show
high
genet
divers
least
five
genogroup
gigv
gi
gii
respons
major
noroviru
infect
human
clone
express
proteas
norwalk
viru
gi
viru
gii
character
enzymat
activ
fluoresc
reson
energi
transfer
substrat
demonstr
gi
gii
proteas
cleav
substrat
deriv
natur
occur
cleavag
site
open
read
frame
orf
noroviru
similar
effici
enzymat
activ
proteas
inhibit
commerci
proteas
inhibitor
includ
chymostatin
interact
chymostatin
norwalk
viru
proteas
valid
nuclear
magnet
reson
nmr
spectroscopi
norovirus
respons
foodor
waterborn
gastroenter
outbreak
human
estim
million
annual
case
us
alon
follow
salmonella
infect
cdc
fankhaus
et
al
symptom
norovir
gastroenter
nausea
vomit
diarrhea
headach
fever
chill
myalgia
sore
throat
usual
last
h
green
et
al
although
norovirus
gener
caus
mild
moder
gastroenter
incapacit
affect
individu
militari
troop
ship
war
zone
green
et
al
sever
lifethreaten
young
elderli
immunocompromis
patient
atmar
est
dolin
recent
studi
shown
norovir
diarrhea
persist
week
rockx
et
al
sakai
et
al
virus
excret
week
rockx
et
al
furthermor
report
noroviru
diarrhea
shed
last
longer
year
immunocompromis
patient
nilsson
et
al
norwalk
viru
nv
first
enter
caliciviru
discov
kapikian
et
al
sinc
discoveri
first
noroviru
least
five
genogroup
establish
genu
noroviru
among
gi
gii
rare
giv
virus
infect
human
gi
gii
norovirus
subdivid
genotyp
green
nv
studi
prototyp
viru
classifi
strain
recent
year
norovirus
becam
predominantli
associ
noroviru
outbreak
sporad
case
worldwid
siebenga
et
al
zheng
et
al
overal
noroviru
strain
belong
gii
found
sporad
case
noroviru
infect
patel
et
al
strain
account
report
noroviru
outbreak
global
kroneman
et
al
siebenga
et
al
howev
vaccin
antivir
drug
current
avail
noroviru
infect
larg
due
absenc
cell
cultur
system
anim
model
human
norovirus
norovirus
show
high
divers
immun
one
strain
necessarili
provid
protect
infect
anoth
strain
addit
inadequ
longterm
immun
norovirus
indic
repeat
infect
adult
glass
et
al
green
although
norovirus
multipli
food
water
caus
larg
outbreak
virion
suffici
caus
ill
healthi
adult
green
norovirus
classifi
niaid
categori
b
prioriti
pathogen
niaid
due
highli
contagi
natur
potenti
caus
seriou
public
health
challeng
therefor
develop
antivir
drug
highli
desir
prevent
treat
noroviru
infect
norovirus
singlestrand
rna
virus
encod
three
open
read
frame
orf
nonstructur
polyprotein
minor
major
structur
protein
gene
organ
noroviru
nonstructur
polyprotein
encod
ntermin
protein
nterm
ntpase
protein
vpg
proteas
pro
rnadepend
rna
polymeras
pol
green
et
al
fig
noroviru
proteas
specif
recogn
cleav
lqgp
ntermntpas
lqgp
pegk
vpg
feap
vpgpro
legg
propol
junction
produc
matur
protein
viral
replic
belliot
et
al
hardi
et
al
liu
et
al
sosnovtsev
et
al
noroviru
proteas
classifi
cystein
proteas
due
similar
picornaviru
proteas
catalyt
triad
amino
acid
compos
c
h
e
green
nakamura
et
al
sinc
noroviru
proteas
essenti
viral
replic
viral
proteas
repres
attract
target
antivir
drug
develop
design
screen
antivir
agent
target
viral
proteas
greatli
facilit
avail
assay
suitabl
larg
scale
screen
potenti
novel
drug
target
viral
proteas
fluoresc
reson
energi
transfer
fret
proteas
assay
develop
provid
rapid
specif
identif
proteas
inhibitor
variou
cellular
viral
proteas
includ
footandmouth
viru
sever
acut
respiratori
syndrom
sar
coronaviru
blanchard
et
al
chen
et
al
jaulent
et
al
assay
system
substrat
fluoresc
donor
quencher
end
donor
fluoresc
signal
uncleav
substrat
inhibit
interact
fluoresc
donor
quencher
substrat
cleav
proteas
donor
fluoresc
longer
quench
yield
increas
fluoresc
intens
addit
proteas
inhibitor
assay
inhibit
cleavag
substrat
lead
reduc
fluoresc
intens
enabl
screen
potenti
proteas
inhibitor
fret
proteas
assay
system
also
use
tool
measur
activ
substrat
specif
proteas
far
inform
proteolyt
process
noroviru
proteas
obtain
use
vitro
transcriptiontransl
assay
system
belliot
et
al
hardi
et
al
scheffler
et
al
seah
et
al
someya
takeda
limit
studi
report
kinet
gi
noroviru
proteas
use
fluorogen
someya
et
al
chromogen
substrat
hussey
et
al
howev
studi
gii
noroviru
proteas
avail
furthermor
fretbas
proteas
assay
suitabl
highthroughput
screen
proteas
inhibitor
yet
report
noroviru
proteas
gi
gii
norovirus
zeitler
et
al
studi
describ
develop
applic
highthroughput
fret
assay
use
noroviru
proteas
nv
nvpro
viru
belong
genogroup
ii
respect
base
assay
similar
kinet
paramet
fluorogen
substrat
inhibit
select
standard
proteas
inhibitor
includ
chymostatin
observ
nvpro
bind
chymostatin
nvpro
also
studi
valid
interact
use
nuclear
magnet
reson
nmr
spectroscopi
nvpro
exhibit
enzymat
activ
similar
cleavag
effici
substrat
k
cat
k
fig
tabl
suggest
abl
effici
recogn
cleav
substrat
deriv
cleavag
site
gi
noroviru
proteas
show
higher
cleavag
effici
toward
truncat
substrat
dfhlqgp
indic
higher
k
cat
k
valu
compar
substrat
residu
epdfhlqgpedlak
tabl
mutant
nv
proteas
increas
fluoresc
signal
addit
substrat
expect
data
shown
edansdfhlqgpdabcyl
use
substrat
experi
z
factor
measur
distanc
standard
deviat
posit
fluoresc
signal
neg
background
control
assay
use
evalu
overal
qualiti
highthroughput
screen
assay
ingles
et
al
zhang
et
al
z
factor
greater
consid
robust
reliabl
indic
assay
system
screen
purpos
blanchard
et
al
zhang
et
al
fig
scatter
plot
fluoresc
unit
posit
neg
control
well
show
assay
rang
data
variat
mean
z
factor
fret
proteas
assay
use
nvpro
edansdfhlqgpdabcyl
substrat
calcul
demonstr
excel
signaltobackground
ratio
robust
sensit
assay
effect
dmso
fretassay
nvpro
determin
shown
fig
dmso
concentr
final
concentr
vv
significantli
affect
enzymat
activ
indic
assay
toler
dmso
experi
studi
contain
less
dmso
four
commerci
avail
serin
proteas
inhibitor
chymostatin
leupeptin
tpck
tlck
papainlik
cystein
proteas
inhibitor
antipain
use
probe
inhibitor
specif
proteas
chymostatin
tpck
markedli
decreas
noroviru
genom
organ
proteolyt
map
cleavag
protein
site
occur
effici
cleavag
site
gi
gii
norovirus
cleavag
dipeptid
b
cleavag
dipeptid
surround
residu
site
gi
gii
norovirus
design
substrat
residu
start
scissil
bond
count
toward
cterminu
respect
suggest
schechter
berger
tabl
result
indic
proteas
two
predomin
noroviru
genogroup
share
similar
inhibitor
profil
sinc
chymostatin
significantli
inhibit
noroviru
proteas
fret
assay
bind
chymostatin
nvpro
valid
use
nmr
spectroscopi
seri
n
hsqc
spectra
nvpro
increas
concentr
chymostatin
analyz
identifi
residu
nvpro
involv
interact
chymostatin
nmr
chemic
shift
perturb
backbon
amid
h
n
reson
n
hsqc
spectra
sensit
probe
chang
chemic
environ
surround
amino
acid
residu
andor
rel
popul
differ
conform
protein
structur
ensembl
shuker
et
al
weight
chemic
shift
differ
n
reson
nvpro
presenc
vari
concentr
chymostatin
compar
observ
absenc
chymostatin
fig
signific
chemic
shift
chang
observ
chymostatin
titrat
concentrationdepend
manner
fig
b
indic
specif
interact
nvpro
chymostatin
hand
pb
compound
ad
unrel
control
caus
signific
chemic
shift
perturb
nvpro
fig
presenc
molar
excess
chymostatin
residu
nvpro
show
significantli
shift
residu
could
trace
due
peak
disappear
andor
line
broaden
mark
asterisk
largest
posit
valu
fig
linebroaden
effect
like
indic
chemic
exchang
slow
time
scale
due
conform
dynam
nvpro
interact
chymostatin
corrobor
result
obtain
nvprochymostatin
interact
use
nmr
spectroscopi
construct
dock
model
nvpro
complex
chymostatin
use
haddock
program
de
vri
et
al
dominguez
et
al
dock
experiment
inform
interfac
nvpro
chymostatin
deriv
nmr
chemic
shift
perturb
requir
ambigu
interact
restraint
air
drive
dock
two
molecul
base
nvpro
chemic
shift
perturb
observ
presenc
chymostatin
higher
solvent
access
design
activ
residu
air
addit
catalyt
import
residu
display
signific
perturb
lower
solvent
access
also
select
activ
residu
adjac
activ
residu
defin
passiv
residu
posit
activ
passiv
residu
nvpro
indic
structur
fig
b
result
dock
calcul
sever
differ
cluster
similar
haddock
score
obtain
cluster
indic
chymostatin
posit
near
activ
substrat
bind
site
nvpro
structur
ensembl
lowest
energi
cluster
rmsd
valu
backbon
atom
repres
structur
lower
energi
cluster
present
fig
structur
favor
energi
valu
van
der
waal
energi
kcal
mol
electrostat
energi
kcal
mol
higher
restraint
violat
energi
kcalmol
higher
violat
mostli
due
unbias
select
activ
residu
show
chemic
shift
perturb
clearli
seen
fig
sever
residu
direct
interact
chymostatin
highli
probabl
residu
distant
bind
site
indirectli
affect
experienc
certain
degre
conform
chang
upon
bind
chymostatin
dock
model
depict
fig
demonstr
chymostatin
bound
nvpro
canon
substrat
bind
mode
also
suggest
nmr
data
nvprochymostatin
interact
occur
mainli
ctermin
domain
arch
form
two
cii
cover
chymostatin
norovirus
lead
caus
foodor
waterborn
gastroenter
outbreak
worldwid
affect
million
peopl
us
alon
noroviru
infect
caus
debilit
ill
peopl
age
group
militari
base
well
cruis
ship
school
hospit
norovirus
requir
viral
particl
initi
infect
highli
contagi
moreov
longlast
immun
follow
natur
infect
rare
develop
peopl
consid
challeng
antivir
drug
control
noroviru
infect
urgent
need
noroviru
proteas
known
respons
critic
virusmedi
posttransl
cleavag
polypeptid
encod
viral
protein
therefor
inhibit
viral
proteas
capac
prevent
viral
replic
sever
viral
proteas
inhibitor
market
develop
pathogen
virus
human
immunodefici
viru
hepat
c
viru
sar
coronaviru
ghosh
et
al
kazmierski
et
al
tsantrizo
walker
et
al
robust
reliabl
assay
high
throughput
screen
potenti
noroviru
proteas
inhibitor
greatli
facilit
develop
antivir
drug
viral
proteas
genogroup
ii
norovirus
associ
major
noroviru
infect
human
amino
acid
homolog
proteas
among
gi
norovirus
homolog
gi
gii
noroviru
proteas
howev
amino
acid
sequenc
analysi
show
key
residu
catalyt
site
residu
form
subsit
conserv
gi
gii
norovirus
ng
parra
cotranscript
translat
assay
studi
use
enzymat
activ
gii
proteas
suggest
substrat
specif
requir
similar
nv
gi
base
western
blot
radioact
microsequenc
map
belliot
et
al
howev
littl
inform
compar
kinet
properti
proteas
gi
gii
norovirus
therefor
develop
fret
proteas
assay
highthroughput
capabl
use
screen
noroviru
proteas
inhibitor
studi
substrat
inhibitor
specif
noroviru
proteas
gi
gii
norovirus
conserv
amino
acid
sequenc
cleavag
site
nv
norovirus
differ
fy
pg
residu
posit
report
import
maxim
activ
earlier
map
studi
cleavag
site
recogn
caliciviru
proteas
hardi
et
al
studi
cleav
substrat
span
residu
cleavag
site
nv
effici
similar
nvpro
indic
recogn
cleav
substrat
h
f
posit
respect
effici
nvpro
addit
nvpro
cleav
substrat
residu
effici
substrat
residu
suggest
residu
necessari
substrat
bind
cleavag
proteas
result
line
earlier
report
pnitroanilin
peptid
residu
effici
cleav
gi
proteas
southampton
strain
compar
contain
residu
substrat
residu
cleav
hussey
et
al
addit
chiba
viru
proteas
gi
substrat
complex
model
base
crystal
structur
suggest
substrat
bind
stabil
interact
substrat
residu
correspond
bind
site
proteas
nakamura
et
al
evalu
inhibitor
specif
nvpro
use
set
commerci
avail
standard
proteas
inhibitor
noroviru
proteas
structur
similar
chymotrypsin
superfamili
base
xray
crystallographi
nakamura
et
al
zeitler
et
al
standard
proteas
inhibitor
share
common
mechan
action
although
share
primari
sequenc
threedimension
structur
bode
huber
laskowski
kato
screen
proteas
inhibitor
assay
reveal
activ
proteas
significantli
inhibit
presenc
chymostatin
tpck
detail
kinet
studi
inhibit
nvpro
chymostatin
confirm
proteas
similar
inhibit
profil
suggest
proteas
inhibitor
may
develop
multipl
noroviru
genogroup
addit
versatil
assay
allow
incorpor
proteas
differ
genogroup
screen
compound
variou
noroviru
genogroup
perform
qualiti
suitabl
fret
assay
high
throughput
screen
demonstr
high
z
factor
interact
chymostatin
nvpro
valid
nmr
studi
analysi
nmr
chemic
shift
map
data
reveal
reson
residu
involv
substrat
bind
site
activ
site
greatli
affect
chymostatin
exhibit
strong
inhibitori
effect
proteas
contain
glf
moieti
previou
structur
studi
interact
chymotrypsin
serin
standard
proteas
inhibitor
show
side
chain
residu
f
chymostatin
fit
specif
subsit
chymotrypsin
carbonyl
oxygen
extend
toward
oxyanion
hole
form
g
residu
locat
activ
site
enzym
residu
chymostatin
also
interact
enzym
form
short
antiparallel
interact
coomb
et
al
interact
repres
substratelik
bind
mode
enzym
dock
result
use
haddock
base
nmr
chemic
shift
perturb
studi
indic
chymostatin
specif
interact
nvpro
canon
bind
mode
seen
proteasesubstratesubstratedirect
inhibitor
complex
stage
abl
give
clear
answer
whether
chymostatin
coval
modifi
nucleophil
thiol
group
form
hemithioacet
adduct
form
noncoval
enzymeinhibitor
complex
howev
result
indic
critic
residu
catalysi
target
chymostatin
conclus
demonstr
develop
applic
fret
noroviru
proteas
gi
gii
assay
highthroughput
capabl
screen
potenti
antivir
compound
monitor
enzymat
reaction
interact
chymostatin
noroviru
proteas
nmr
spectroscopi
result
provid
valuabl
inform
studi
antivir
enzym
activ
fulllength
codonoptim
cdna
correspond
complet
amino
acid
sequenc
nvpro
synthes
clone
vector
genscript
piscataway
nj
synthes
cdna
sequenc
includ
start
stop
codon
well
sequenc
encod
ntermin
six
h
ni
column
purif
plasmid
encod
nvpro
transform
e
coli
cell
protein
express
regular
luriabertani
broth
induct
mm
isopropyl
iptg
h
shake
incub
harvest
cell
sonic
ultracentifug
proteas
solubl
supernat
appli
ninta
affin
column
qiagen
valencia
ca
purif
mutant
nvpro
c
nucleophil
substitut
posit
gener
sitedirect
mutagenesi
protein
monom
size
approxim
kda
determin
size
exclus
chromatographi
fig
contrast
previou
report
noroviru
proteas
stabli
form
dimer
nvpro
predominantli
dimer
solut
southampton
viru
proteas
hussey
et
al
zeitler
et
al
interestingli
preliminari
xray
crystallographi
reveal
nvpro
dimer
suggest
histag
nterminu
interfer
dimer
data
shown
result
indic
concentr
andor
condit
prepar
proteas
may
influenc
monomerdim
equilibrium
nvpro
nmr
studi
uniformli
nlabel
nvpro
express
e
coli
cell
grown
minim
media
supplement
gl
cl
cambridg
isotop
laboratori
andov
purifi
previous
describ
takahashi
et
al
briefli
cell
contain
express
plasmid
encod
nvpro
grown
starter
cultur
consist
ml
luria
bertani
media
h
cell
grown
minim
media
od
valu
induc
mm
iptg
h
cell
harvest
centrifug
subsequ
resuspend
buffer
contain
mm
sodium
phosphat
ph
mm
sodium
chlorid
mm
imidazol
sonic
centrifug
cell
lysat
nvpro
purifi
cell
lysat
supernat
use
ninta
affin
column
qiagen
valencia
ca
size
exclus
chromatographi
superdex
prep
grade
ge
healthcar
amersham
uk
appli
final
purif
step
gelfiltr
standard
biorad
hercul
ca
contain
thyroglobulin
kda
kda
ovalbumin
kda
myoglobin
kda
use
analyz
molecular
weight
elut
protein
nmr
sampl
contain
uniformli
nlabel
nvpro
mm
mm
sodium
phosphat
ph
mm
nacl
mm
dtt
mm
nan
h
unless
otherwis
note
two
fluorogen
substrat
edansepdfhlqgpedlakdabcyl
zeitler
et
al
edansdfhlqgpdabcyl
deriv
residu
cleavag
site
nv
respect
synthes
genscript
piscataway
nj
design
substrat
residu
start
scissil
bond
count
toward
cterminu
respect
suggest
schechter
berger
stock
solut
mm
substrat
prepar
dmso
dilut
assay
buffer
mm
hepe
buffer
ph
contain
mm
nacl
mm
edta
glycerol
mm
dtt
correct
factor
inner
filter
effect
background
substrat
control
well
without
proteas
subtract
rel
fluoresc
unit
rfu
correct
inner
filter
effect
inner
filter
effect
produc
higher
substrat
concentr
due
absorpt
fluoresc
quencher
adjac
substrat
caus
attenu
fluoresc
intens
abolish
linear
correl
cleav
substrat
concentr
fluoresc
intens
cuerrier
et
al
jaulent
et
al
briefli
serial
dilut
edan
refer
standard
free
edan
ad
well
plate
without
equal
concentr
substrat
fluoresc
read
obtain
micropl
reader
correct
factor
compens
inner
filter
effect
determin
empir
describ
previous
cuerrier
et
al
jaulent
et
al
correct
rfu
convert
concentr
product
proteas
reaction
plot
edan
fluoresc
refer
standard
rfu
versu
concentr
initi
veloc
v
rate
enzym
reaction
calcul
use
first
min
progress
curv
plot
substrat
concentr
michaelismenten
plot
use
graphpad
prism
program
graphpad
softwar
san
diego
ca
determin
ratio
k
cat
k
measur
effici
catalyt
reaction
specif
constant
substrat
edansdfhlqgpdabcyl
final
concentr
ad
well
contain
nvpro
final
concentr
posit
control
well
assay
buffer
neg
control
well
black
plate
sinc
z
factor
depend
mean
standard
deviat
combin
well
plate
incub
h
fluoresc
read
obtain
mean
standard
deviat
fluoresc
calcul
neg
posit
well
determin
z
factor
previous
describ
blanchard
et
al
ingles
et
al
p
standard
deviat
posit
control
n
standard
deviat
neg
control
p
mean
posit
control
n
mean
neg
control
investig
toler
assay
toward
dmso
solvent
typic
use
dissolv
test
compound
reaction
contain
nvpro
fluorogen
substrat
edansdfhlqgpdabcyl
assay
buffer
supplement
dmso
dmso
concentr
vari
vv
otherwis
constant
condit
fluoresc
measur
follow
incub
min
reaction
perform
triplic
determin
effect
dmso
enzym
activ
commerci
avail
standard
proteas
inhibitor
includ
serin
proteas
inhibitor
chymostatin
leupeptin
ntosyllphenylalanin
chloromethyl
keton
tpck
tosylllysin
chloromethyl
keton
tlck
papainlik
cystein
proteas
inhibitor
antipain
obtain
sigmaaldrich
st
loui
mo
stock
solut
mm
inhibitor
prepar
dmso
dilut
assay
buffer
fig
purif
nvpro
histag
nvpro
purifi
size
exclus
chromatographi
b
sdspage
analysi
purifi
nvpro
untag
version
proteas
predict
molecular
weight
kda
proteas
shift
slightli
higher
molecular
weight
assay
exceed
volvol
nvpro
final
concentr
substrat
edansdfhlqgpdabcyl
give
strong
signal
minim
inner
filter
effect
use
studi
inhibitor
final
concentr
preincub
nvpro
min
volum
substrat
ad
black
plate
follow
incub
mixtur
incub
fluoresc
read
obtain
micropl
reader
min
incub
substrat
concentr
use
pilot
screen
well
k
substrat
deplet
observ
control
well
without
inhibitor
min
incub
time
reduct
cleav
product
prepar
calcul
comparison
control
without
inhibitor
continu
monitor
activ
kinet
nvpro
perform
evalu
detail
efficaci
chymostatin
proteas
final
concentr
mix
serial
dilut
chymostatin
assay
buffer
incub
min
follow
addit
variou
concentr
substrat
mixtur
incub
fluoresc
read
obtain
micropl
reader
everi
min
min
rfu
correct
inner
filter
effect
convert
concentr
product
proteas
reaction
dissoci
constant
inhibitor
bind
ki
valu
determin
nonlinear
regress
analysi
use
graphpad
prism
softwar
dosedepend
fret
inhibit
curv
fit
variabl
slope
four
paramet
use
graphpad
prism
softwar
order
determin
concentr
chymostatin
reduc
enzym
veloc
half
ic
ic
valu
determin
presenc
substrat
min
nmr
experi
perform
varian
vnmr
mhz
spectromet
equip
mm
tripl
reson
invers
detect
cryogen
nmr
probe
nmr
spectra
process
use
nmrpipe
delaglio
et
al
analyz
sparki
goddard
kneller
cara
softwar
http
wwwnmrch
keller
inhibitor
titrat
experi
carri
direct
addit
mm
stock
solut
chymostatin
dissolv
dmsod
cambridg
isotop
laboratori
andov
uniformli
nlabel
nvpro
solut
n
hsqc
spectra
nvpro
monitor
addit
equival
chymostatin
complex
point
spectral
width
ppm
use
record
spectra
recent
report
total
backbon
h
n
reson
assign
free
nvpro
takahashi
et
al
assign
hsqc
spectra
presenc
chymostatin
use
investig
interact
inhibitor
follow
peak
shift
titrat
sinc
use
dmsod
cosolv
caus
slight
traceabl
reson
peak
shift
dosedepend
manner
titrat
repeat
dmsod
alon
spectrum
vari
amount
chymostatin
compar
dmsod
correspond
titrat
point
control
similar
experi
repeat
use
unrel
compound
dissolv
dmsod
inhibit
nvpro
activ
pb
compound
chemic
shift
chang
character
use
weight
chemic
shift
differ
h
n
grzesiek
et
al
dock
model
nvpro
complex
chymostatin
built
use
haddock
highambigu
driven
biomolecular
dock
program
de
vri
et
al
dominguez
et
al
experiment
inform
residu
involv
intermolecular
interact
use
ambigu
interact
restraint
air
drive
dock
protein
residu
directli
involv
intermolecular
interact
defin
activ
residu
neighbor
residu
activ
residu
passiv
residu
haddock
dock
protocol
consist
threestag
procedur
rigidbodi
energi
minim
semiflex
refin
torsion
angl
space
final
refin
explicit
solvent
crystal
structur
nvpro
pdb
code
zeitler
et
al
use
start
structur
nvpro
residu
show
peak
disappear
chemic
shift
perturb
greater
averag
shift
valu
ppm
n
hsqc
spectrum
nvpro
chymostatin
possess
higher
solvent
access
select
activ
residu
solvent
access
calcul
use
getarea
robert
fraczkiewicz
residu
defin
solvent
expos
ratio
sidechain
surfac
area
random
coil
valu
exce
solvent
access
surfac
neighbor
activ
residu
defin
passiv
residu
dock
calcul
whole
residu
small
ligand
chymostatin
select
activ
residu
initi
total
structur
calcul
rigid
bodi
minim
stage
calcul
lowestenergi
structur
select
subsequ
semiflex
simul
anneal
refin
explicit
solvent
final
structur
cluster
use
backbon
rootmeansquar
deviat
rmsd
cutoff
structur
drawn
pymol
delano
student
ttest
use
compar
signific
unpair
sampl
mean
p
valu
b
consid
signific
